Diagnostic anti-[ebola virus (EV)] antibodies pairs for testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays
Product Details
Ebola Virus Disease (EVD) is a rare and deadly disease in people and nonhuman primates. The viruses that cause EVD are located mainly in sub-Saharan Africa. People can get EVD through direct contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with Ebola virus.
The U.S. Food and Drug Administration (FDA) has approved the Ebola vaccine rVSV-ZEBOV (tradename “Ervebo”) for the prevention of EVD. The rVSV-ZEBOV vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-ebola virus (EV) monoclonal antibodies for rapid test kit of ebola virus (EV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).
All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in diagnostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.
Product Description
|
Antigen & Antibody Name
|
Mouse anti-ebola virus (EV) monoclonal antibodies
|
|
Expression platform
|
Hybridoma
|
|
Isotypes
|
Mouse IgG
|
|
Bioactivity validation
|
Antibody Binding,
Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in[ebola virus (EV)] level test in human infectious disease diagnositcs.
|
|
Tag
|
mFc
|
|
Products description
|
Ebola Virus Disease (EVD) is a rare and deadly disease in people and nonhuman primates. The viruses that cause EVD are located mainly in sub-Saharan Africa. People can get EVD through direct contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with Ebola virus.
The U.S. Food and Drug Administration (FDA) has approved the Ebola vaccine rVSV-ZEBOV (tradename “Ervebo”) for the prevention of EVD. The rVSV-ZEBOV vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus.
|
|
Purity
|
Purity: ≥95% （SDS-PAGE）
|
|
Application
|
Paired antibody immunoassay validation in sandwich Elisa,Lateral flow immunoassay (LFIA),and other immunoassays;
|
|
Formulation
|
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
|
Cat No.
|
GMP-EV-1Ab
|
|
Product Name
|
|
|
Expression platform
|
|
|
Isotypes
|
|
|
Bioactivity validation
|
|
|
Tag
|
|
|
Products description
|
|
|
Purity
|
|
|
Application
|
|
|
Formulation
|
|
|
Storage
|
|
Diagnostic antibodies and antigens for infectious disease testing including HIV/AIDS, HCV, Influenza A/B, Syphilis, Helicobacter pylori, HSV-1/2, CMV, rubella virus, toxoplasma.
Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction.
Genemedi produces core diagnostic ingredients for test of infectious diseases and related syndrome.
GeneMedi offers paired diagnostics grade antibodies (monoclonal antibody,mab)and antigens for infectious disease rapid test kit including infection of HIV/AIDS,Hepatitis C virus(HCV), Influenza A/B,Treponema Pallidum caused Syphilis,Helicobacter pylori (H. pylori) Bacteria, Herpes simplex virus 1/2(HSV-1/HSV-2),Cytomegalovirus (CMV),rubella virus,toxoplasma gondii and so on.
All the antibodies of inflammation and CRS test are suitable for in functional ELISA, and other immunoassays in dignostics. The antibody can act as a capture antibody and detection antibody.
